These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 26035354

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer.
    Seshacharyulu P, Ponnusamy MP, Rachagani S, Lakshmanan I, Haridas D, Yan Y, Ganti AK, Batra SK.
    Oncotarget; 2015 Mar 10; 6(7):5164-81. PubMed ID: 25686822
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer.
    Kaur S, Sharma N, Krishn SR, Lakshmanan I, Rachagani S, Baine MJ, Smith LM, Lele SM, Sasson AR, Guha S, Mallya K, Anderson JM, Hollingsworth MA, Batra SK.
    Clin Cancer Res; 2014 Feb 01; 20(3):688-700. PubMed ID: 24240113
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased expression of EHF contributes to thyroid tumorigenesis through transcriptionally regulating HER2 and HER3.
    Lv Y, Sui F, Ma J, Ren X, Yang Q, Zhang Y, Guan H, Shi B, Hou P, Ji M.
    Oncotarget; 2016 Sep 06; 7(36):57978-57990. PubMed ID: 27517321
    [Abstract] [Full Text] [Related]

  • 10. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells.
    Chaturvedi P, Singh AP, Chakraborty S, Chauhan SC, Bafna S, Meza JL, Singh PK, Hollingsworth MA, Mehta PP, Batra SK.
    Cancer Res; 2008 Apr 01; 68(7):2065-70. PubMed ID: 18381409
    [Abstract] [Full Text] [Related]

  • 11. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma.
    Pai P, Rachagani S, Lakshmanan I, Macha MA, Sheinin Y, Smith LM, Ponnusamy MP, Batra SK.
    Mol Oncol; 2016 Feb 01; 10(2):224-39. PubMed ID: 26526617
    [Abstract] [Full Text] [Related]

  • 12. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer.
    Kumar S, Das S, Rachagani S, Kaur S, Joshi S, Johansson SL, Ponnusamy MP, Jain M, Batra SK.
    Oncogene; 2015 Sep 10; 34(37):4879-89. PubMed ID: 25531332
    [Abstract] [Full Text] [Related]

  • 13. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
    Chaturvedi P, Singh AP, Moniaux N, Senapati S, Chakraborty S, Meza JL, Batra SK.
    Mol Cancer Res; 2007 Apr 10; 5(4):309-20. PubMed ID: 17406026
    [Abstract] [Full Text] [Related]

  • 14. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
    Yang K, He M, Cai Z, Ni C, Deng J, Ta N, Xu J, Zheng J.
    Pancreas; 2015 Apr 10; 44(3):370-9. PubMed ID: 25522282
    [Abstract] [Full Text] [Related]

  • 15. The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
    Vasseur R, Skrypek N, Duchêne B, Renaud F, Martínez-Maqueda D, Vincent A, Porchet N, Van Seuningen I, Jonckheere N.
    Biochim Biophys Acta; 2015 Dec 10; 1849(12):1375-84. PubMed ID: 26477488
    [Abstract] [Full Text] [Related]

  • 16. Upregulation of the splice variant MUC4/Y in the pancreatic cancer cell line MIA PaCa-2 potentiates proliferation and suppresses apoptosis: new insight into the presence of the transcript variant of MUC4.
    Xie K, Zhi X, Tang J, Zhu Y, Zhang J, Li Z, Tao J, Xu Z.
    Oncol Rep; 2014 May 10; 31(5):2187-94. PubMed ID: 24676527
    [Abstract] [Full Text] [Related]

  • 17. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.
    Balz LM, Bartkowiak K, Andreas A, Pantel K, Niggemann B, Zänker KS, Brandt BH, Dittmar T.
    J Pathol; 2012 Jun 10; 227(2):234-44. PubMed ID: 22262199
    [Abstract] [Full Text] [Related]

  • 18. Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer.
    Joshi S, Cruz E, Rachagani S, Guha S, Brand RE, Ponnusamy MP, Kumar S, Batra SK.
    Mol Oncol; 2016 Aug 10; 10(7):1063-77. PubMed ID: 27185392
    [Abstract] [Full Text] [Related]

  • 19. The role of the AMOP domain in MUC4/Y-promoted tumour angiogenesis and metastasis in pancreatic cancer.
    Tang J, Zhu Y, Xie K, Zhang X, Zhi X, Wang W, Li Z, Zhang Q, Wang L, Wang J, Xu Z.
    J Exp Clin Cancer Res; 2016 Jun 10; 35(1):91. PubMed ID: 27287498
    [Abstract] [Full Text] [Related]

  • 20. A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy.
    Lee-Hoeflich ST, Crocker L, Yao E, Pham T, Munroe X, Hoeflich KP, Sliwkowski MX, Stern HM.
    Cancer Res; 2008 Jul 15; 68(14):5878-87. PubMed ID: 18632642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.